Paroxysmal Nocturnal Hemoglobinuria (PNH)
The outcome varies. Most people survive greater than 10 years after their diagnosis. Death can result from complications such as blood clot formation (thrombosis) or bleeding.
Soliris (eculizumab) is a drug used to treat PNH. It blocks the breakdown of red blood cells.
Soliris affects your immune system, and using this medication may increase your risk of serious infection such as meningitis.
You must be vaccinated against meningococcal infection at least 2 weeks before you start treatment with Soliris.
- Soliris Information for Consumers
- Soliris Information for Healthcare Professionals (includes dosage details)
- Side Effects of Soliris (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 6 Oct 2010 • 1 answer
Posted 14 Jan 2012 • 1 answer
Posted 11 Feb 2012 • 1 answer
Posted 19 Jun 2014 • 2 answers
Posted 28 Aug 2014 • 2 answers